Css LLC Novavax Inc Call Options Transaction History

Css LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $19,450 - $104,850	5,000 New	5,000 $63,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $67,367 - $96,152	10,100 New	10,100 $75,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $270,230 - $763,720	30,500 Added 87.39%	65,400 $672,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $140,140 - $586,124	-7,700 Reduced 18.08%	34,900 $635,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $613,132 - $1.27 Million	-16,900 Reduced 28.4%	42,600 $2.19 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $3.97 Million - $8.15 Million	57,000 Added 2280.0%	59,500 $4.38 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.06 Million - $1.72 Million	-7,900 Reduced 75.96%	2,500 $358,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $2.65 Million - $4.03 Million	-14,900 Reduced 58.89%	10,400 $2.16 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $2.52 Million - $5.36 Million	-20,800 Reduced 45.12%	25,300 $5.37 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $3.11 Million - $8.8 Million	27,500 Added 147.85%	46,100 $8.36 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $1.19 Million - $2.11 Million	15,100 Added 431.43%	18,600 $2.08 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $516,360 - $1.16 Million	-6,500 Reduced 65.0%	3,500 $379,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $138,600 - $836,100	10,000 New	10,000 $834,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.